Maxcyte (MXCT) Finished Goods (2020 - 2026)

Maxcyte (MXCT) has 7 years of Finished Goods data on file, last reported at $3.5 million in Q1 2026.

• Quarterly Finished Goods fell 3.08% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (down 3.08% YoY) and the FY2025 annual result came in at $3.2 million, down 18.97% from the prior year.
• Finished Goods climbed to $3.5 million in Q1 2026 per MXCT's latest filing, from $3.2 million in the prior quarter.
• Across five years, Finished Goods topped out at $6.0 million in Q1 2024 and bottomed at $2.7 million in Q3 2022.
• The 5-year median for Finished Goods is $3.5 million (2023), against an average of $4.0 million.
• The widest annual swing landed in 2023, when Finished Goods jumped 121.46%; it then tumbled 40.19% in 2025.
• Tracing MXCT's Finished Goods over 5 years: stood at $2.9 million in 2022, then jumped by 103.99% to $6.0 million in 2023, then tumbled by 34.3% to $3.9 million in 2024, then declined by 18.97% to $3.2 million in 2025, then increased by 9.87% to $3.5 million in 2026.
• Per Business Quant, the three latest MXCT Finished Goods figures stand at $3.5 million (Q1 2026), $3.2 million (Q4 2025), and $3.3 million (Q3 2025).

Peer Comparison